A Valuable Surgical Allograft 

Success of amnion-derived allografts in repairing soft tissue defects has been well documented over the past century.  Recent advances in processing technology render minimally manipulated allografts that preserve the native biologic structures of these tissues, delivering unprecedented results.  Amnio therapy has proven to be an invaluable modality in the treatment of chronic wounds, pressure ulcers, diabetic foot ulcers, trauma, and other difficult-to-heal soft tissue injuries.  Amniotic membrane has proven an invaluable barrier to separate and protect the natural planes of the human body.

Click to Vew Article: Soft Tissue Repair and Regeneration Using Postpartum-Derived Cells

Improving Outcomes with Amnio Therapy

Amnio-derived allografts have been an effective modality to reduce scarring, minimize risk of adhesions, and heal tissue faster after surgery.  Amnion-derived therapies work by releasing essential Growth Factors as well as recruiting stem cells to the site of damage to promote tissue regeneration.  Stem cells are primitive cells that can undergo differentiation to form different types of cells in the body, such as bone, blood, cartilage, tendon, ligaments, etc. These cells are responsible for healing tissue damages by generating new healthy cells. However, with age, the body loses its ability to attract enough stem cells to the site of injury. In this regard, amnio therapy delivers a high concentration of proteins, carbohydrates, cytokines, keratinocytes and growth factors to feed stem cells at the affected area to promote rapid, natural healing.